Amgen Inc. said it will pay Roche Holding AG $137.5 million to gain control over European assets and business related to two white-cell boosters that are sold in the U.S. under the names Neupogen and Neulasta. (BioWorld Today)
In a three-year collaboration entered Tuesday with Cephalon Inc., Novuspharma SpA will use its preclinical research technology to screen a number of cancer compounds provided by Cephalon. (BioWorld Today)
In a three-year collaboration entered Tuesday with Cephalon Inc., Novuspharma SpA will use its preclinical research technology to screen a number of cancer compounds provided by Cephalon. (BioWorld Today)
In another step toward completing the merger of Immunex Corp. and Amgen Inc., the former on Friday said it has found a buyer for its cancer drug, Leukine. (BioWorld Today)
In another step toward completing the merger of Immunex Corp. and Amgen Inc., the former on Friday said it has found a buyer for its cancer drug, Leukine. (BioWorld Today)
WASHINGTON - Sen. Orrin Hatch recently told a group of lawyers here that he usually votes on the side of science - that is, sound science. (BioWorld Today)
WASHINGTON - Sen. Orrin Hatch recently told a group of lawyers here that he usually votes on the side of science - that is, sound science. (BioWorld Today)
